Healthcare -
Biotechnology - NYSE - US
$ 1.98
0.508 %
$ 666 M
Market Cap
-0.91
P/E
NUVB - STOCK-BASED COMPENSATION
Stock-based Compensation NUVB - Nuvation Bio Inc.
19.5 M
LAST VALUE
45.10%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR